| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2006;37:2361.)
© 2006 American Heart Association, Inc.
Original Contributions |
From the Laboratory of Neurogenesis and Cell Therapy (T.K., P.T., R.K., O.L.), Section of Restorative Neurology, Wallenberg Neuroscience Center, University Hospital; the Laboratory of Neural Stem Cell Biology (H.A., Z.K.), Section of Restorative Neurology, Stem Cell Institute, University Hospital; and the Lund Strategic Research Center for Stem Cell Biology and Cell Therapy (T.K., H.A., P.T., R.K., Z.K., O.L.), Lund, Sweden.
Correspondence to Olle Lindvall, MD, PhD, Laboratory of Neurogenesis and Cell Therapy, Section of Restorative Neurology, Wallenberg Neuroscience Center, University Hospital, SE-221 84, Lund, Sweden. E-mail olle.lindvall{at}med.lu.se
Background and Purpose Stroke triggers increased progenitor proliferation in the subventricular zone (SVZ) and the generation of medium spiny neurons in the damaged striatum of rodents. We explored whether intrastriatal infusion of glial cell line-derived neurotrophic factor (GDNF) promotes neurogenesis after stroke.
Methods Adult rats were subjected to 2-hour middle cerebral artery occlusion (MCAO). GDNF was infused into the ischemic striatum either during the first week after MCAO, with the animals being killed directly thereafter, or during the third and fourth weeks, with the rats being killed 1 week later. New cells were labeled with 5'-bromo-2'deoxyuridine (BrdU) on day 7 or during the second week, respectively. Neurogenesis was assessed immunocytochemically with antibodies against BrdU and neuronal, glial, or progenitor markers. GDNF receptor expression was analyzed in SVZ tissue and neurospheres by reverse transcriptionpolymerase chain reaction and immunocytochemistry.
Results GDNF infusion increased cell proliferation in the ipsilateral SVZ and the recruitment of new neuroblasts into the striatum after MCAO and improved survival of new mature neurons. The GDNF receptor GFR
1 was upregulated in the SVZ 1 week after MCAO and was coexpressed with markers of dividing progenitor cells.
Conclusions Intrastriatal infusion of GDNF in the postischemic period promotes several steps of striatal neurogenesis after stroke, partly through direct action on SVZ progenitors. Because delivery of GDNF has biological effects in the human brain, our data suggest that administration of this factor may promote neuroregenerative responses in stroke patients.
Key Words: cerebral ischemia corpus striatum middle cerebral artery occlusion nerve growth factors stem cells
This article has been cited by other articles:
![]() |
T. Hagg From Neurotransmitters to Neurotrophic Factors to Neurogenesis Neuroscientist, February 1, 2009; 15(1): 20 - 27. [Abstract] [PDF] |
||||
![]() |
T. Trapp, G. Kogler, A. El-Khattouti, R. V. Sorg, M. Besselmann, M. Focking, C. P. Buhrle, I. Trompeter, J. C. Fischer, and P. Wernet Hepatocyte Growth Factor/c-MET Axis-mediated Tropism of Cord Blood-derived Unrestricted Somatic Stem Cells for Neuronal Injury J. Biol. Chem., November 21, 2008; 283(47): 32244 - 32253. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |